DNA methylation signatures of aggression and closely related constructs:A meta-analysis of epigenome-wide studies across the lifespan by van Dongen, Jenny et al.
                          van Dongen, J., Relton, C. L., Hagenbeek, F., & Suderman, M. J.
(2021). DNA methylation signatures of aggression and closely related
constructs: A meta-analysis of epigenome-wide studies across the
lifespan. Molecular Psychiatry, (2021). https://doi.org/10.1038/s41380-
020-00987-x
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1038/s41380-020-00987-x
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Springer Nature at
https://doi.org/10.1038/s41380-020-00987-x . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the





DNA methylation signatures of aggression and closely related constructs:
A meta-analysis of epigenome-wide studies across the lifespan
Jenny van Dongen 1 ● Fiona A. Hagenbeek 1 ● Matthew Suderman2,3 ● Peter J. Roetman 4 ● Karen Sugden5,6 ●
Andreas G. Chiocchetti 7 ● Khadeeja Ismail 8 ● Rosa H. Mulder9,10,11 ● Jonathan D. Hafferty12 ● Mark J. Adams 12 ●
Rosie M. Walker 13 ● Stewart W. Morris13 ● Jari Lahti 14,15 ● Leanne K. Küpers 16 ● Georgia Escaramis 17,18,19 ●
Silvia Alemany 20,21,22 ● Marc Jan Bonder 23 ● Mandy Meijer 24,25 ● Hill F. Ip 1 ● Rick Jansen 26 ●
Bart M. L. Baselmans1 ● Priyanka Parmar27,28 ● Estelle Lowry 27,29 ● Fabian Streit 30 ● Lea Sirignano 30 ●
Tabea S. Send31 ● Josef Frank 30 ● Juulia Jylhävä32 ● Yunzhang Wang32 ● Pashupati Prasad Mishra33 ●
Olivier F. Colins 4,34 ● David L. Corcoran 6 ● Richie Poulton 35 ● Jonathan Mill 36 ● Eilis Hannon 36 ●
Louise Arseneault 37 ● Tellervo Korhonen8 ● Eero Vuoksimaa8 ● Janine F. Felix 11,38 ●
Marian J. Bakermans-Kranenburg 39 ● Archie Campbell 13 ● Darina Czamara 40 ● Elisabeth Binder 40,41 ●
Eva Corpeleijn16 ● Juan R. Gonzalez 20,21,22 ● Regina Grazuleviciene 42 ● Kristine B. Gutzkow43 ● Jorunn Evandt43 ●
Marina Vafeiadi 44 ● Marieke Klein 24,25,45 ● Dennis van der Meer 46,47 ● Lannie Ligthart 1 ● BIOS Consortium ●
Cornelis Kluft48 ● Gareth E. Davies49 ● Christian Hakulinen15 ● Liisa Keltikangas-Järvinen15 ● Barbara Franke 24,25,50 ●
Christine M. Freitag 7 ● Kerstin Konrad 51,52 ● Amaia Hervas53 ● Aranzazu Fernández-Rivas54 ● Agnes Vetro55 ●
Olli Raitakari56,57,58 ● Terho Lehtimäki 33 ● Robert Vermeiren4,59 ● Timo Strandberg60 ● Katri Räikkönen15 ●
Harold Snieder 16 ● Stephanie H. Witt 30 ● Michael Deuschle31 ● Nancy L. Pedersen32 ● Sara Hägg 32 ●
Jordi Sunyer20,21,22,61 ● Lude Franke23 ● Jaakko Kaprio 8 ● Miina Ollikainen 8 ● Terrie E. Moffitt5,6,37,62 ●
Henning Tiemeier 10,63 ● Marinus H. van IJzendoorn 64,65 ● Caroline Relton2,3 ● Martine Vrijheid 20,21,22 ●
Sylvain Sebert 27,28,66 ● Marjo-Riitta Jarvelin 27,28,67 ● Avshalom Caspi5,6,37,62 ● Kathryn L. Evans 13 ●
Andrew M. McIntosh 12 ● Meike Bartels 1 ● Dorret I. Boomsma 1
Received: 27 January 2020 / Revised: 4 November 2020 / Accepted: 4 December 2020
© The Author(s) 2021. This article is published with open access
Abstract
DNA methylation profiles of aggressive behavior may capture lifetime cumulative effects of genetic, stochastic, and
environmental influences associated with aggression. Here, we report the first large meta-analysis of epigenome-wide
association studies (EWAS) of aggressive behavior (N= 15,324 participants). In peripheral blood samples of 14,434
participants from 18 cohorts with mean ages ranging from 7 to 68 years, 13 methylation sites were significantly associated
with aggression (alpha= 1.2 × 10−7; Bonferroni correction). In cord blood samples of 2425 children from five cohorts with
aggression assessed at mean ages ranging from 4 to 7 years, 83% of these sites showed the same direction of association with
childhood aggression (r= 0.74, p= 0.006) but no epigenome-wide significant sites were found. Top-sites (48 at a false
discovery rate of 5% in the peripheral blood meta-analysis or in a combined meta-analysis of peripheral blood and cord
blood) have been associated with chemical exposures, smoking, cognition, metabolic traits, and genetic variation (mQTLs).
Three genes whose expression levels were associated with top-sites were previously linked to schizophrenia and general risk
tolerance. At six CpGs, DNA methylation variation in blood mirrors variation in the brain. On average 44% (range=
3–82%) of the aggression–methylation association was explained by current and former smoking and BMI. These findings
point at loci that are sensitive to chemical exposures with potential implications for neuronal functions. We hope these
results to be a starting point for studies leading to applications as peripheral biomarkers and to reveal causal relationships
with aggression and related traits.
Biobank-based Integrative Omics Study Consortium. For a complete
list of authors, see below acknowledgements.
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Aggression encompasses a range of behaviors, such as
bullying, verbal abuse, fighting, and destroying objects.
Early life social conditions, including low parental income,
separation from a parent, family dysfunction, and maternal
smoking during pregnancy are risk factors for childhood
aggression [1–3]. High levels of aggression are a char-
acteristic of several psychiatric disorders and may also be
caused by traumatic brain injury [3], neurodegenerative
diseases [4] and alcohol and substance abuse [5, 6].
DNA methylation mediates effects of genetic variants in
regulatory regions on gene expression [7] and is modifiable
by early life social environment, as demonstrated by animal
studies [8, 9], and by chemical exposures including (prenatal)
exposure to cigarette smoke, as illustrated by numerous
human studies [10]. Despite the large tissue-specificity of
DNA methylation, effects of genetic variants on nearby DNA
methylation (cis mQTLs) correlate strongly between blood
and brain cells [11]. DNA methylation signatures of chemical
exposures [12] and maternal rearinging [9] show a certain (but
less understood) degree of conservation across tissues.
Large-scale epigenome-wide association studies
(EWASs) have become feasible through DNA methylation
microarrays applied to blood samples from large cohorts,
identifying thousands of loci where methylation in cord
blood is associated with maternal smoking [13]. Methyla-
tion in blood is associated with depressive symptoms [14]
and brain morphology [15], with some evidence for blood
DNA methylation signatures being a marker for methylation
levels [15] or gene expression [14] in the brain. For several
traits, DNA methylation scores based on multiple CpGs
from EWAS show better predictive value than currently
available polygenic scores [16, 17].
Small-scale studies (maximum sample size= 260) have
provided some evidence that DNA methylation differences
in blood, cord blood, and buccal cells are associated with
severe forms of aggressive behavior and related problems in
children and adults, including (chronic) physical aggression
and early onset conduct problems [18–20], but studies on
violent aggression in schizophrenia patients (N= 134) [21]
and a population-based study of continuous aggression
symptoms in adults (N= 2029) [22] did not detect
epigenome-wide significant sites.
We performed an EWAS meta-analysis of aggressive
behavior and closely related constructs. We chose to meta-
analyze multiple measures of aggression across ages and
sex to maximize sample size. The contribution of genetic
influences to aggression is largely stable, at least throughout
childhood [23], whereas epigenetic signatures may be
dynamic and may differ across cell types and age. There-
fore, we performed separate meta-analyses of peripheral
blood collected after birth (N= 14,434) and cord blood
(N= 2425), followed by a combined meta-analysis (N=
15,324) including an examination of heterogeneity of
effects. Next, we tested the relationship between aggressive
behavior and epigenetic clocks, as associations of lifetime
stress [24], exposure to violence [25], and psychiatric dis-
orders [26, 27] with accelerated epigenetic ageing have
been reported. We performed extensive functional follow-
up by integrating our findings with data on gene expression,
mQTLs and DNA methylation in brain samples.
Methods
Cohorts
Demographic information for the cohorts is provided in
Table 1. Detailed cohort information is provided in eAp-
pendix 1. Informed consent was obtained from all partici-
pants. The protocol for each study was approved by the
ethical review board of each institution.
Aggressive behavior
Aggressive behavior was assessed by self-report or reported
by parents and teachers. Multiple instruments were used
(eTable 1): ASEBA Child Behavior Check List (CBCL)
[28], Strengths and Difficulties Questionnaire (SDQ) con-
duct problem scale [29], Multidimensional Peer Nomination
Inventory (MNPI) aggression scale [30], ASEBA adult self-
report (ASR) aggression scale [31], DSM-IV Conduct
Disorder Symptom Scale [32], Multidimensional Person-
ality Questionnaire (MPQ) aggression scale [33], and the
Hunter–Wolf aggressive behavior scale [34, 35]. In four
cohorts, a single aggression-related item from personality
questionnaires was used. Distributions of aggression scores
are provided in eFig. 1.
DNA methylation BeadChips
DNA methylation was assessed with Illumina BeadChips:
the llumina Infinium HumanMethylation450 BeadChip
(450k array; majority of cohorts), or the Illumina Methy-
lationEPIC BeadChip (EPIC array). Most cohorts analyzed
DNA methylation β-values, which range from 0 to 1,
indicating the proportion of DNA that is methylated at a
CpG in a sample. Cohort-specific details about DNA
methylation profiling, quality control, and normalization are
described in eAppendix 1 and summarized in eTable 2.
Epigenome-wide association analysis
EWAS analyses were performed according to a standard
operating procedure (http://www.action-euproject.eu/
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content/data-protocols). In each cohort, the association
between DNA methylation level and aggressive behavior
was specified under a linear model with DNA methylation
as outcome, and correction for relatedness of individuals
where applicable. Two models were tested. Model 1
included aggressive behavior, sex, age at blood sampling
(not in cohorts with invariable age), white blood cell per-
centages (measured or imputed), and technical covariates.
Model 2 included the same predictors plus body-mass-index
(BMI) and smoking status in adolescents and adults (current
smoker, former smoker or never smoked). Cohort-specific
details and R-code are provided in eAppendix 1 and
eTable 3, respectively. The relationship between aggressive
behavior and covariates is provided in eTable 4 based on
data from the Netherlands Twin Register (N= 2059).
Quality control and filtering of cohort-level EWAS
summary statistics is described in eAppendix 2. The fol-
lowing probes were removed: on sex chromosomes,
methylation sites with more than 5% missing data in a
cohort, probes overlapping SNPs affecting the CpG or
single base extension site with a minor allele frequency
(MAF) > 0.01 in the 1000 G EU or GONL population [7],
and ambiguous mapping probes reported with an overlap of
at least 47 bases per probe [36]. The R package Bacon was
used to compute the Bayesian inflation factor and to obtain
bias- and inflation-corrected test statistics (eFig. 2) prior to
meta-analysis [37]. Further data can be found in the sup-
plementary material for this paper, eFigs. 1–18
Meta-analysis
Fixed-effects meta-analyses were performed in METAL [38].
We used the p-value-based (sample size-weighted) method
because the measurement scale of aggressive behavior differs
across studies. First, results based on peripheral blood and
cord blood data were meta-analyzed separately. Second, a
combined meta-analysis was performed of all data. The fol-
lowing cohorts had data available for both cord blood and
peripheral blood (from the same children): INMA (which is
part of HELIX) and ALSPAC. In the combined meta-analy-
sis, the cord blood data from ALSPAC and INMA were
excluded to avoid sample overlap. Statistical significance was
assessed considering Bonferroni correction for the number of
sites tested (alpha= 1.2 × 10−7). Methylation sites that were
associated with aggression at the less conservative false dis-
covery rate (FDR) threshold (5%) were included in follow-up
analyses. The I2 statistic from METAL was used to describe
heterogeneity.
Follow-up analyses
DNA methylation score analyses and epigenetic clock
analyses are described in eAppendix 3 and eAppendix 4.
Follow-up analyses (eAppendix 5- eAppendix 10) were
performed on meta-analysis top-sites (FDR < 0.05),
including a comparison of top-sites with all previously
reported associations in the EWAS atlas [39], follow-up
analysis of top-sites in two clinical cohorts with blood
methylation data (Table 2), a cross-tissue analysis (blood,
buccal, brain), and association with gene expression level
and mQTLs. Analyses of differentially methylated regions
(DMRs) are described in eAppendix 8. Finally, we per-
formed replication analysis of a previously reported DMR
associated with aggression [20] (eAppendix 9).
Results
Peripheral blood meta-analysis
We performed a meta-analysis of 13 studies with peripheral
blood DNA methylation data (N= 14,434). The meta-
analysis test statistics showed no inflation (eTable 5,
eFig. 3). In model 1, methylation at 13 CpGs was associated
with aggression (Bonferroni correction; alpha= 1.2 × 10−7),
and 35 passed a less conservative threshold (FDR 5%;
Fig. 1a). At 28 out of the 35 sites (80%), higher levels of
aggression were associated with lower methylation levels.
Top-sites showed varying degrees of between-study hetero-
geneity (mean I2= 50%; range= 0–86%, eTable 6). Five
sites showed significant heterogeneity (alpha= 1.2 × 10−7).
Cord blood meta-analysis
The meta-analysis of cord blood (five cohorts; N= 2425)
detected no significant CpGs (eTable 7). Examining
top-sites from the peripheral blood meta-analysis, 12 of the
significant, and 33 of the FDR top-sites were assessed in
cord blood; 10 (83%), and 25 (71%), respectively, showed
the same direction of association (Fig. 1b). Effect sizes in
cord blood correlated significantly with effect sizes in per-
ipheral blood (r= 0.74, p= 0.006 for epigenome-wide
significant and r= 0.51, p= 0.003 for FDR top-sites).
Combined meta-analysis
In the combined meta-analysis of peripheral and cord blood
data (total sample size= 15,324, eTable 6), methylation at
13 CpGs was associated with aggression after Bonferroni
correction, including ten CpGs from the peripheral blood
meta-analysis, and 43 passed a less conservative threshold
(FDR 5%, Table 3). Among FDR top-sites from both ana-
lyses, 13 CpGs were only found in the combined meta-
analysis but not in the peripheral blood meta-analysis, while
five CpGs from the peripheral blood meta-analysis were no
longer significant in the combined meta-analysis (Fig. 1c).
J. van Dongen et al.
CBCL meta-analysis
We compared our meta-analysis results to a meta-analysis
of cohorts that applied the same aggression instrument; i.e.
CBCL (four studies; N= 2286; Table 1). No epigenome-
wide significant sites were detected (eFig. 4a). Examining
top-sites from the overall meta-analysis (Model 1), 38
(79%) showed the same direction of association for CBCL
aggression in children, and effect sizes correlated strongly
(r= 0.75, p= 6.8 × 10−10, eFig. 4b).
Overlap with CpGs detected in previous EWASs
We performed enrichment analyses against all previously
reported associations with diseases and environmental
exposures recorded in the EWAS Atlas [39]. The top ten
most strongly enriched traits are shown in Fig. 1e. CpGs
associated with aggressive behavior showed large overlap
with CpGs previously associated with smoking (37 CpGs;
corresponding to 77% of aggression-associated CpGs and
0.3% of CpGs that have been previously associated with
smoking), and smaller overlap with other smoking traits
(e.g. maternal smoking), other chemical exposures (e.g.
perinatal exposure to polychlorinated biphenyls (PCBs) and
polychlorinated dibenzofurans (PCDFs)). Further overlap
includes CpGs associated with alcohol consumption, cog-
nitive function, educational attainment, ageing, and meta-
bolic traits (eTable 8).
Controlling for smoking and BMI
Model 2 was fitted to test whether the association between
DNA methylation and aggressive behavior attenuated after
adjusting for the most important postnatal lifestyle factors
that influence DNA methylation (smoking and BMI).
Examining 17,457 CpGs associated with smoking [40],
previously reported effect sizes for smoking correlated
significantly with effect sizes for aggression from our meta-
analysis (r= 0.55, p < 1 × 10−16, eFig. 5a). Examining the
35 CpGs associated with aggression at FDR 5% in per-
ipheral blood, all CpGs showed the same direction of
association with aggression after adjusting for smoking and
BMI (eTable 6, Fig. 1d). Effect sizes were attenuated to
varying degrees (mean reduction= 44%, range= 3–83%).
Changes in effect sizes are likely primarily driven by the
correction for smoking, since only one top-site has been
associated previously with BMI. Some CpGs showed little
attenuation, in particular CpGs that have not been pre-
viously associated with smoking (e.g.; cg02895948;
PLXNA2, cg00891184; KIF1B, cg1215892; intergenic, and
cg05432213; ACT1; eFig. 5b). In model 2, between-study
heterogeneity at top-sites was greatly reduced (adjusted:
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epigenome-wide significant or FDR-significant in the
adjusted meta-analyses.
DNA methylation scores
We computed weighted sumscores in NTR (peripheral
blood, mean age= 36.4, SD= 12, N= 2,059) based on
summary statistics from the peripheral blood meta-analysis
without NTR (Fig. 2). The best score, based on CpGs with
p < 1 × 10−3 in model 2 (745 CpGs), explained 0.29% of the
variance in aggression (p= 0.02, not significant after mul-
tiple testing correction). This effect was attenuated when
age and sex were added to the prediction equation.
Epigenetic clocks
Horvath and Hannum epigenetic age acceleration were not
associated with aggression (eTable 9) in a meta-analysis of
Fig. 1 DNA methylation associated with aggressive behavior in a
large blood-based meta-analysis. aManhattan plot showing the fixed
effects meta-analysis p values for the association between aggressive
behavior and DNA methylation level based on the meta-analysis of
peripheral blood. The blue horizontal line denotes the FDR-threshold
(5%) and the red line indicates the Bonferroni threshold. b Effects
sizes of top-sites from the meta-analysis of aggression in peripheral
blood (x-axis) versus effects sizes from the meta-analysis of aggression
in cord blood (y-axis). c Venn diagram showing the numbers and
overlap of CpGs detected at FDR 5% in the meta-analysis of periph-
eral blood and the combined meta-analysis and cord blood and per-
ipheral blood. d Effects sizes of top-sites from the meta-analysis of
aggression in peripheral blood model 1 (x-axis) versus effects sizes
from the meta-analysis of aggression in peripheral blood model 2;
adjusted for smoking and BMI (y-axis). e Top enriched traits based on
enrichment analysis with all 48 top-sites. The third column shows how
many of the 48 CpGs have been previously associated with the trait in
the first column. The last column shows the overlap as a percentage of
the total number of CpGs previously associated with the trait in col-
umn 1 (e.g. 0.3% of all CpGs previously associated with smoking are
also associated with aggression in the current meta-analysis). d In
b and d, CpGs that have not been previously associated with smoking
in the meta-analysis by Joehanes et al. [40] are plotted in red.
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Table 3 Top-sites associated with aggressive behavior from the combined EWAMA of cord blood and peripheral blood (FDR 5%).
CpG ID CHR Positiona Gene Gene Expression Associated With
CpGs
N M1 Z score M1 P value M1 Z score M2 P value M2
cg05575921 5 373378 AHRR EXOC3 15,666 −8.995 2.36E-19 −4.159 3.20E-05
cg21161138 5 399360 AHRR EXOC3 15,661 −7.573 3.66E-14 −3.155 1.61E-03
cg26703534 5 377358 AHRR EXOC3 15,665 −6.695 2.16E-11 −2.058 3.96E-02
cg14753356 6 30720108 FLOT1 15,666 −6.672 2.52E-11 −3.342 8.33E-04
cg22132788 7 45002486 MYO1G 10,847 6.313 2.74E-10 3.637 2.76E-04
cg06126421 6 30720080 FLOT1, TUBB, LINC00243 10,864 −6.196 5.78E-10 −2.154 3.13E-02
cg07826859 7 45020086 MYO1G 10,863 −6.017 1.77E-09 −3.665 2.48E-04
cg09935388 1 92947588 GFI1 15,661 −5.906 3.51E-09 −3.222 1.27E-03
cg25648203 5 395444 AHRR EXOC3 15,657 −5.583 2.37E-08 −2.233 2.55E-02
cg12062133 8 142548839 14,482 5.462 4.71E-08 4.881 1.06E-06
cg05951221 2 233284402 10,864 −5.443 5.25E-08 −1.679 9.32E-02
cg14817490 5 392920 AHRR EXOC3 10,863 −5.407 6.43E-08 −2.152 3.14E-02
cg14179389 1 92947961 GFI11 15,666 −5.35 8.80E-08 −3.888 1.01E-04
cg05432213 15 35086985 ACTC1 15,666 5.144 2.68E-07 4.87 1.12E-06
cg03636183 19 17000585 F2RL3 F2RL3 15,666 −5.124 3.00E-07 −0.909 3.63E-01
cg09022230 7 5457225 TNRC18 15,666 −5.071 3.95E-07 −3.024 2.49E-03
cg12803068 7 45002919 MYO1G RP4-647J21.1 15,666 4.93 8.22E-07 2.493 1.27E-02
cg23916896 5 368804 AHRR 15,652 −4.915 8.86E-07 −2.332 1.97E-02
cg04180046 7 45002736 MYO1G RP4-647J21.1 15,665 4.884 1.04E-06 2.989 2.80E-03
cg02228160 5 143192067 HMHB1 10,852 4.867 1.13E-06 3.451 5.58E-04
cg03519879 14 74227499 C14orf43 15,663 −4.859 1.18E-06 −3.609 3.08E-04
cg00310412 15 74724918 SEMA7A SEMA7A 15,666 −4.854 1.21E-06 −2.608 9.11E-03
cg13165240 17 3715743 C17orf85 15,664 4.838 1.31E-06 4.436 9.16E-06
cg02895948 1 208204062 PLXNA2 PLXNA2 10,865 −4.811 1.51E-06 −4.448 8.68E-06
cg12147622 10 74021432 15,662 −4.796 1.62E-06 −3.312 9.26E-04
cg26883434 5 111091560 C5orf13 14,540 4.773 1.81E-06 4.739 2.15E-06
cg03991871 5 368447 AHRR EXOC3 10,857 −4.753 2.01E-06 −2.374 1.76E-02
cg06946797 16 11422409 15,666 −4.75 2.03E-06 −3.317 9.08E-04
cg00891184 1 10272185 KIF1B 15,662 4.746 2.07E-06 4.421 9.82E-06
cg09243533 1 19281949 IFFO2 15,666 −4.74 2.14E-06 −4.003 6.26E-05
cg03935116 12 31476565 FAM60A FAM60A 15,665 −4.735 2.19E-06 −3.664 2.48E-04
cg11554391 5 321320 AHRR 15,666 −4.717 2.39E-06 −2.731 6.32E-03
cg19825437 3 169383292 15,664 −4.663 3.12E-06 −3.094 1.98E-03
cg00624037 12 89315201 15,663 4.633 3.61E-06 4.081 4.49E-05
cg01940273 2 233284934 15,666 −4.621 3.82E-06 −0.305 7.61E-01
cg25949550 7 145814306 CNTNAP2 15,666 −4.615 3.94E-06 −2.333 1.96E-02
cg23067299 5 323907 AHRR 10,865 4.615 3.94E-06 3.21 1.33E-03
cg04387347 16 88537187 ZFPM1 9563 4.603 4.17E-06 2.678 7.42E-03
cg02325250 5 131409289 CSF2 15,664 −4.597 4.28E-06 −3.635 2.78E-04
cg14560430 3 32863175 TRIM71 15,665 −4.569 4.90E-06 −3.924 8.70E-05
cg03844894 15 35086967 ACTC1 15,666 4.567 4.94E-06 4.176 2.97E-05
cg21611682 11 68138269 LRP5 14,859 −4.561 5.08E-06 −1.721 8.53E-02
cg20673321 19 48049233 ZNF541 15,666 4.538 5.67E-06 4.672 2.98E-06
aGenome build 37. M1=Model 1: correction for sex, age at blood sampling, white blood cell percentages (measured or imputed), and technical
covariates. M2=Model 2 included the same predictors plus body-mass-index (BMI) and smoking status in adolescents and adults (current
smoker, former smoker or never smoked). Note that no CpGs were epigenome-wide significant or FDR-significant in the adjusted meta-analyses
(model 2).
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12 studies with peripheral blood DNA methylation data
(N= 9554), five studies with cord blood DNA methylation
(N= 2,225), or in a combined meta-analysis of 15 studies
(N= 9740). There was no significant heterogeneity between
cohorts (mean I2= 16%, range= 0–60%).
Follow-up in clinical cohorts
To assess the translation of our observations to aggression-
related problem behavior in psychiatric disorders that show
comorbidity with aggression, we performed follow-up
analyses of top-sites in two clinical cohorts (Table 2): the
NeuroIMAGE [41] cohort of ADHD cases and controls
(Ntotal= 71) and the FemNAT-CD [42] cohort of female
conduct disorder cases and controls (Ntotal= 100). Results
did not replicate (eAppendix 6, eTable 10, eTable 11,
eFig. 6, eFig. 7).
Cross-tissue analysis
To assess the generalizability of our observations in blood
to other tissues, we examined the association with CBCL
aggression in buccal DNA methylation data (EPIC array),
available for 38 top-sites, in a twin cohort (N= 1237) and a
child clinical cohort (N= 172; Table 2, eTable 12) [43]. We
also tested associations with maternal smoking and with
child nervous system medication (as indexed by the Ana-
tomical Therapeutic Chemical classification system (ATC
N-class))
Correlations between DNA methylation levels in blood
and buccal cells, based on 450k data from matched samples
(N= 22, age= 18 years) [44] were available for 36 of these
CpGs. The average correlation was weak (r= 0.25, range
=−0.40–0.76). Five CpGs showed a strong correlation
between blood and buccal cells (r > 0.5, eTable 13), of
which three have been previously associated with (mater-
nal) smoking.
In line with the weak correlation between blood and buccal
cell methylation for most top-sites, none of the top-sites was
associated with aggression in buccal samples (alpha= 0.001,
eTable 14). Regression coefficients based on analyses in buccal
cells and blood overall showed no directional consistency (twin
cohort: r= 0.03, p= 0.86; concordant direction: 47%, p=
0.87, binomial test, clinical cohort: r= 0.27, p= 0.10; con-
cordant direction: 61%, p= 0.26). Exclusion of ancestry out-
liers did not change these results (eTable 14). Of the five CpGs
with a large blood-buccal correlation, three showed the same
direction of association with aggression in buccal cells from
twins, four in clinical cases, and one CpG was nominally
associated with aggression in buccal samples from twins;
cg11554391 (AHRR), rblood-buccal= 0.69, βaggression=−0.0002,
p= 0.007.
Fig. 2 Prediction of aggression by DNA methylation scores. The
bars indicate how much of the variance in ASEBA adult self-report
(ASR) aggression scores were explained by DNA methylation scores
in NTR (N= 2059, peripheral blood, 450k array). Scores were created
based on weights from the peripheral blood meta-analysis with NTR
excluded (N= 12,375). The y-axis shows percentage of variance
explained. Different colors denote DNA methylation scores created
with different numbers of CpGs that were selected on their p value in
the meta-analysis (see legend). From left to right, the first three plots
show DNA methylation scores created based on weights obtained from
the meta-analysis of EWAS model 1, and plots 4 till 6 show DNA
methylation scores created based on weights obtained from the meta-
analysis of EWAS model 2. Each DNA methylation score was tested
for association with aggression in three model: the simplest model
(first plot) included aggression as outcome variable, and DNA
methylation score as predictor plus technical covariates and cell
counts. The second model additionally included sex and age as pre-
dictors. The third model additionally included sex, age, and smoking
as predictors. Stars denote nominal p values < 0.05 (not corrected for
multiple testing).
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One CpG was significantly associated with maternal
smoking in both cohorts: cg04180046 (MYO1G), NTR:
βmaternalsmoking= 0.041, p= 6.0 × 10−6, Curium: βmaternals-
moking= 0.048, p= 7.9 × 10−5 (eTable 14). None of the
CpGs was associated with medication use of the child
(eTable 14).
We examined the correlation between DNA methylation
levels in blood and brain (N= 122) [45] in published DNA
methylation data from matched blood samples and four
brain regions. Six aggression top-sites (13%) showed sig-
nificantly correlated DNA methylation levels between blood
and one or multiple brain regions: mean r= 0.52; range=
0.45–0.63, alpha= 2.6 × 10−4, eTable 15, eFig. 8), two of
which have not been previously associated with smoking or
BMI: cg14560430(TRIM71), and cg20673321(ZNF541).
DMRs
DMR analysis showed that 14 DMPs from our combined
meta-analysis reside in regions where multiple correlated
methylation sites showed evidence for association with
aggressive behavior. DMR analysis also detected additional
regions that were not significant in DMP analysis
(eTable 16- eTable 21). These analyses are described in
detail in eAppendix 8.
Replication analysis
A previous EWAS based on Illumina array data detected a
significant DMR in DRD4 in buccal cells associated with
engagement in physical fights [20]. This locus did not
replicate in our meta-analyses or in the two cohorts with
buccal methylation data (eTable 22, eAppendix 9).
Gene expression
Based on peripheral blood RNA-seq and DNA methylation
data (N= 2101) [7], 17 significant DNA methylation-gene
expression associations were identified among 15 CpGs and
ten transcripts (Table 3, eTable 23). For most transcripts, a
higher methylation level at a CpG site in cis correlated with
lower expression (82.4%): cg03935116 and FAM60A,
cg00310412 and SEMA7A, cg03707168 and PPP1R15A,
cg03636183 and F2RL3, two intergenic CpGs on chromo-
some 6, where methylation level correlated negatively with
expression levels of FLOT1, TUBB, and LINC00243, and
six CpGs annotated to AHRR were negatively associated
with EXOC3 expression level. Positive correlations were
observed between methylation levels at 2 CpGs on chro-
mosome 7 and levels of RP4-647J21.1 (novel transcript,
overlapping MYO1G) and between cg02895948 and
PLXNA2.
mQTLs
To gain insight into genetic causes of variation underlying
top-sites, we obtained whole-blood mQTL data (N= 3841)
[7]. In total, 75 mQTL associations were identified among
34 aggression top-sites (70.8%) and 66 SNPs at the
experiment-wide threshold applied by the mQTL study
FDR < 0.05): 80% were cis mQTLs and 20% were trans
mQTLs (eTable 24).
Discussion
We identified 13 epigenome-wide significant sites (Bon-
ferroni corrected) in the meta-analysis of blood and 13 in
the combined meta-analysis of blood and cord blood (16
unique sites). We prioritized 48 top-sites (FDR 5%) for
follow-up analyses. Methylation level at three top-sites was
associated with expression levels of genes that have been
previously linked to psychiatric or behavioral traits in
GWASs: FLOT1 (schizophrenia [46]), TUBB (schizo-
phrenia) [46], and PLXNA2 (general risk tolerance) [47].
Several other loci have functions in the brain and six CpGs
showed correlated methylation levels between blood
and brain.
The majority of top-sites (77%) were associated with
smoking, 46% were associated with maternal smoking, 25%
were associated with alcohol consumption, and 15% were
associated with perinatal PCB and PCDF exposure. This
overlap of aggression top-sites with smoking and other
chemical exposures is noteworthy. Methylation levels of
top-sites in the Aryl-Hydrocarbon Receptor Repressor gene
AHRR and several other genes are known to be strongly
associated with exposure to cigarette smoke [13, 40] and
persistent organic pollutants [48]. The best characterized
exogenous ligands of the widely expressed Aryl-
Hydrocarbon Receptor are environmental contaminants
such as benzo[a]pyrene (B[a]P), and TCDD (dioxin), whose
neurotoxic and neuroendocrine effects, including disruption
of neuronal proliferation, differentiation, and survival, have
been well characterized [49]. Human prenatal exposure to B
[a]P is associated with delayed mental development, lower
IQ, anxiety and attention problems [50]. Research on B[a]P
neurotoxicity in adults is scarce but a study on coke oven
workers found that occupational B[a]P exposure correlates
with reduced monoamine, amino acid and choline neuro-
transmitter levels and with impaired learning and memory
[51].
On average 44% (range= 3–82%) of the aggression–
methylation association was explained by current and for-
mer smoking and BMI. Our findings do not merely reflect
effects of own smoking: 71% of the top-sites showed the
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same direction for the prospective association of cord blood
methylation at birth and aggression in childhood, and 46%
have been associated with maternal prenatal smoking. There
is a weak observational association between maternal
smoking and child aggression [52]. A limitation of our
study is that the EWAS analyses did not adjust for prenatal
and postnatal second-hand smoking, and did not adjust for
smoking intensity and duration or other substance use.
Future studies can examine if the link between prenatal
maternal smoking and aggression is mediated by DNA
methylation.
We found that DNA methylation scores for aggression
explained less variation compared to DNA methylation
scores for traits such as BMI, smoking, and educational
attainment. For these traits, EWASs tended to identify more
epigenome-wide significant hits [16, 17]. The variance in
aggression explained by DNA methylation scores was in the
same order of magnitude as the variance in height explained
by DNA methylation scores (based on EWASs of height in
smaller samples), i.e. <1% [16]. More research is needed in
particular to delineate a causal link between these methy-
lation sites and aggressive behaviour, since our results may
also reflect (residual) confounding by (exposure to second-
hand) smoking. One approach to address this could be
Mendelian Randomization, in which genetic information
(SNPs) is used for causal inference of the effect of an
exposure (e.g. DNA methylation) on an outcome (e.g.,
aggression). This approach previously supported a causal
effect of maternal smoking-associated methylation sites in
blood on various traits and diseases for which well-powered
GWASs have been performed, including schizophrenia
[53, 54]. For aggressive behavior, the currently available
[55] largest GWASs of aggressive behavior included
~16,000 [56] and ~75,000 participants [57], respectively.
The GWAS by Ip et al. detected three significant genes in
gene-based analysis, but both GWASs did not detect
genome-wide significant SNPs and are likely still under-
powered. In the future, larger GWASs of aggressive beha-
vior and larger mQTL analyses will allow for powerful
Mendelian Randomization for aggression-associated
methylation sites.
Strengths and limitations
This is the largest EWAS of aggressive behavior to date.
The large sample size was achieved by applying a broad
phenotype definition, including participants from multiple
countries and all ages in a meta-analysis, and analyzing
DNA methylation data from blood. A limitation of this
approach is that it reduces power to detect age-, sex-, and
symptom-specific effects, and that genetic and environ-
mental backgrounds of different populations, as well as
non-identical processing methods of methylation data play a
role. A limitation of population-based cohorts and even
clinical populations is that individuals with extreme levels
of aggressive behavior who cause most societal problems
are likely underrepresented. Moreover, some studies used
measures that tapped features that overlap with but are not
necessarily indicative of aggression (e.g., personality traits,
anger, oppositional defiant disorder). Future EWASs that
specifically focus on more homogeneous aggression mea-
sures are therefore warranted. Our meta-analysis approach
may identify a common epigenomic signature of
aggression-related problems.
Follow-up analysis in independent datasets indicated that
these findings do not generalize strongly to buccal cells, and
results did not replicate in two clinical cohorts. These were
small, used different aggression measures, and one used a
different technology (sequencing) in females only.
Conclusions
We identified associations between aggressive behavior
and DNA methylation in blood at CpGs whose methyla-
tion level is also associated with exposure to smoking,
alcohol consumption, other chemical exposures, and
genetic variation. Methylation levels at three top-sites
were associated with expression levels of genes that have
been previously linked to psychiatric or behavioral traits
in GWAS. Our study illustrates both the merit of EWASs
based on peripheral tissues to identify environmentally-
driven molecular variation associated with behavioral
traits and their challenges to tease-out confounders and
mediators of the association, and causality. To have full
insight into, and to control for confounders in behavioral
EWAS meta-analyses (which, in addition to smoking-
exposure across the life course likely include other
substance-use and socioeconomic conditions throughout
life and other, perhaps less obvious ones) is challenging.
Future studies, including those that integrate EWAS
results for multiple traits and exposures, DNA methyla-
tion in multiple tissues, and GWASs of multiple traits are
warranted to unravel the utility of our results as peripheral
biomarkers for pathological mechanisms in other tissues
(such as neurotoxicity) and to unravel possible causal
relationships with aggression and related traits. We con-
sider this study to be the starting point for such follow-up
studies.
Code availability
The EWAS R-code is provided in eTable 3.
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